Health Sciences Acquisitions Corporation 2
HSAQ · NASDAQ
12/31/2024 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $2,638 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $204 | $0 | $0 | $0 |
| Gross Profit | $2,434 | $0 | $0 | $0 |
| % Margin | 92.3% | – | – | – |
| R&D Expenses | $42,804 | $0 | $0 | $0 |
| G&A Expenses | $0 | $2,960 | $275 | $130 |
| SG&A Expenses | $23,931 | $2,960 | $275 | $130 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $50 |
| Operating Expenses | $66,735 | $2,960 | $275 | $180 |
| Operating Income | -$64,301 | -$3,080 | -$395 | -$174 |
| % Margin | -2,437.5% | – | – | – |
| Other Income/Exp. Net | $3,277 | $345 | $16 | $0 |
| Pre-Tax Income | -$61,024 | -$2,735 | -$379 | -$174 |
| Tax Expense | $0 | -$345 | -$16 | $0 |
| Net Income | -$61,024 | -$2,390 | -$363 | -$174 |
| % Margin | -2,313.3% | – | – | – |
| EPS | -1.66 | -0.15 | -0.018 | -0.009 |
| % Growth | -1,006.7% | -738% | -108.1% | – |
| EPS Diluted | -1.66 | -0.15 | -0.018 | -0.009 |
| Weighted Avg Shares Out | 36,821,042 | 16,426 | 20,274 | 20,274 |
| Weighted Avg Shares Out Dil | 36,821,042 | 16,426 | 20,274 | 20,274 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $345 | $16 | $0 |
| Interest Expense | $0 | -$345 | -$16 | $0 |
| Depreciation & Amortization | $0 | $345 | $16 | $206 |
| EBITDA | -$64,301 | -$2,735 | -$379 | -$174 |
| % Margin | -2,437.5% | – | – | – |